Literature DB >> 212626

Analgesic activity and opiate receptor binding of 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine.

H Fujimura, K Tsurumi, M Nozaki, M Hori, E Imai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 212626     DOI： 10.1254/jjp.28.505

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN： 0021-5198


× No keyword cloud information.
  4 in total

1.  Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.

Authors:  Michael H Baumann; Susruta Majumdar; Valerie Le Rouzic; Amanda Hunkele; Rajendra Uprety; Xi Ping Huang; Jin Xu; Bryan L Roth; Ying-Xian Pan; Gavril W Pasternak
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

Review 2.  Misuse of Novel Synthetic Opioids: A Deadly New Trend.

Authors:  Matthew P Prekupec; Peter A Mansky; Michael H Baumann
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

3.  Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.

Authors:  Craig McKenzie; Oliver B Sutcliffe; Kevin D Read; Paul Scullion; Ola Epemolu; Daniel Fletcher; Anders Helander; Olof Beck; Alexia Rylski; Lysbeth H Antonides; Jennifer Riley; Shannah A Smith; Niamh Nic Daeid
Journal:  Forensic Toxicol       Date:  2018-04-05       Impact factor: 4.096

4.  Activation of μ-opioid receptors by MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) and its fluorinated derivatives.

Authors:  Daniel T Baptista-Hon; Mark Smith; Samuel Singleton; Lysbeth H Antonides; Niamh Nic Daeid; Craig McKenzie; Tim G Hales
Journal:  Br J Pharmacol       Date:  2020-05-13       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.